Ottonomy, a New York-based maker of autonomous delivery robots, has raised $4.2 million in a post-seed funding round led by Japan-based venture firm Enrission India Capital, according to CEOVine. The company confirmed the round on November 4, 2026, adding to the roughly $1.6 million it had disclosed since its founding in late 2020. Ottonomy says it will spend the capital on deployments already lined up with healthcare and industrial customers over the next three to five months rather than chasing new markets.
The company's robot, the Ottobot, moves medicines, lab samples and equipment through hospitals, airports and factories with minimal human oversight. It runs on what Ottonomy calls Contextual AI, a navigation stack built on 3D lidar and cameras that lets the robot operate indoors and outdoors without GPS and without the extensive pre-mapping many delivery robots require before working a new site.
Why Hospitals Are a Harder Sell Than Sidewalks
Most delivery-robot startups built their first businesses on sidewalks and university campuses, where obstacles are predictable and a stalled robot is a minor nuisance. Hospitals are a different proposition. Elevators, fire doors, crowded corridors and infection-control rules complicate autonomous navigation, and a robot that blocks a hallway can delay a gurney rather than just annoy a pedestrian.
That difficulty is also what makes hospital logistics attractive. Health systems are chronically short-staffed in roles like supply runners and courier aides, and are willing to pay for software that moves materials reliably without new infrastructure such as magnetic strips or dedicated elevators. Ottonomy is betting that the Ottobot hardware it already built for curbside retail and food delivery, which it runs at sites including Cincinnati/Northern Kentucky International Airport, can be reconfigured for hospital corridors rather than rebuilt from scratch.
A Crowded Field With One Dominant Incumbent
Ottonomy's push into healthcare puts it up against Diligent Robotics, whose Moxi robot already runs in more than 25 U.S. hospitals, including Northwestern Medicine and ChristianaCare, and has completed over 1.25 million deliveries. Diligent's advantage widened this year after Serve Robotics acquired the company for $29 million in January, pairing Moxi's indoor manipulation and navigation software with Serve's outdoor delivery fleet, public listing and larger balance sheet.
Against that backdrop, a $4.2 million round is modest, especially compared with the size of robotics deals elsewhere this month: robot-training-data startup GenRobot AI raised $100 million the same week, and warehouse robot operator Tutor Intelligence closed a $75 million Series B. Ottonomy's round buys time and a handful of new deployments rather than the capital needed to match a well-funded incumbent's reach or fund a hardware redesign.
The company's edge is flexibility rather than scale. Because the Ottobot already serves curbside food, retail and e-commerce delivery, Ottonomy can sell variations of the same base platform into hospitals, airports and industrial sites instead of building a separate product line for each vertical, spreading its engineering costs across more use cases than a healthcare-only rival would need to. Enrission India Capital, which typically backs cross-border technology bets between Japan and India, had not previously disclosed a position in delivery robotics; its entry suggests investors are starting to treat autonomous indoor logistics as a fundable category distinct from the humanoid and warehouse-robot deals dominating headlines this year.
Whether that flexibility translates into enough hospital contracts to compete with Diligent's head start is the open question. For now, Ottonomy is choosing to prove out deployments one health system at a time rather than raise a large round it would need to justify spending quickly.